Inventor
CHEN CHUO
US23 patents
⚠️ This page may combine multiple inventors who share the name “CHEN CHUO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNESENSOR THERAPEUTICS INC
12 patentsUS10519188B2Dec 31, 2019
Cyclic di-nucleotide compounds and methods of use
IMMUNESENSOR THERAPEUTICS INC6 citations82
US10947206B2Mar 16, 2021
cGAS antagonist compounds
IMMUNESENSOR THERAPEUTICS INC3 citations72
US11873291B2Jan 16, 2024
Quinoline cGAS antagonist compounds
IMMUNESENSOR THERAPEUTICS INC3 citations71
US11033635B2Jun 15, 2021
Antibody-STING agonist conjugates and their use in immunotherapy
IMMUNESENSOR THERAPEUTICS INC3 citations71
US12065416B2Aug 20, 2024
cGAS antagonist compounds
IMMUNESENSOR THERAPEUTICS INC0 citations62
US11597707B2Mar 7, 2023
CGAS antagonist compounds
IMMUNESENSOR THERAPEUTICS INC1 citations62
US12311030B2May 27, 2025
Antibody-sting agonist conjugates and their use in immunotherapy
IMMUNESENSOR THERAPEUTICS INC0 citations61
US11213592B2Jan 4, 2022
Antibody-sting agonist conjugates and their use in immunotherapy
IMMUNESENSOR THERAPEUTICS INC0 citations61
US11299512B2Apr 12, 2022
Cyclic di-nucleotide compounds and methods of use
IMMUNESENSOR THERAPEUTICS INC0 citations60
US12281078B2Apr 22, 2025
Quinoline cGAS antagonist compounds
IMMUNESENSOR THERAPEUTICS INC0 citations59
US12134609B2Nov 5, 2024
Quinoline cGAS antagonist compounds
IMMUNESENSOR THERAPEUTICS INC0 citations59
US12091387B2Sep 17, 2024
Quinoline cGAS antagonist compounds
IMMUNESENSOR THERAPEUTICS INC0 citations59
UNIV TEXAS
10 patentsUS10336786B2Jul 2, 2019
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
UNIV TEXAS4 citations83
US11492368B2Nov 8, 2022
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
UNIV TEXAS1 citations72
US10633411B2Apr 28, 2020
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
UNIV TEXAS3 citations72
US10508129B2Dec 17, 2019
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
UNIV TEXAS3 citations72
US9783550B2Oct 10, 2017
Highly potent inhibitors of porcupine
UNIV TEXAS3 citations71
US11013704B2May 25, 2021
Compounds supports hematopoietic stem cells and red blood cells
UNIV TEXAS0 citations60
US10696710B2Jun 30, 2020
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
UNIV TEXAS0 citations51
US9045416B2Jun 2, 2015
WNT protein signalling inhibitors
UNIV TEXAS0 citations46
US10420758B2Sep 24, 2019
Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof
UNIV TEXAS0 citations37
US10793544B2Oct 6, 2020
Disubstituted and trisubstituted 1,2,3-triazoles as Wnt inhibitors
UNIV TEXAS0 citations33